HomeAVXL • NASDAQ
Follow
Anavex Life Sciences Corp
Previous close
$5.06
Day range
$4.98 - $5.20
Year range
$4.48 - $10.45
Market cap
417.95M USD
Avg Volume
1.41M
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
(USD) | Dec 2023info | Y/Y change |
---|---|---|
Revenue | — | — |
Operating expense | 10.70M | -26.96% |
Net income | -8.62M | 33.53% |
Net profit margin | — | — |
Earnings per share | -0.11 | 35.29% |
EBITDA | — | — |
Effective tax rate | -1.00% | — |
Balance Sheet
Total assets
Total liabilities
(USD) | Dec 2023info | Y/Y change |
---|---|---|
Cash and short-term investments | 143.76M | 0.10% |
Total assets | 148.07M | -0.20% |
Total liabilities | 12.50M | -5.68% |
Total equity | 135.58M | — |
Shares outstanding | 82.11M | — |
Price to book | 3.07 | — |
Return on assets | -17.69% | — |
Return on capital | -19.29% | — |
Cash Flow
Net change in cash
(USD) | Dec 2023info | Y/Y change |
---|---|---|
Net income | -8.62M | 33.53% |
Cash from operations | -7.32M | -26.30% |
Cash from investing | — | — |
Cash from financing | 59.00K | -77.13% |
Net change in cash | -7.26M | -31.12% |
Free cash flow | -5.38M | -172.05% |
About
Founded
2004
Headquarters
Website
Employees
40